Avadel Pharmaceuticals (AVDL) PT Raised to $15 at Oppenheimer as FTC Favors Over JAZZ
Tweet Send to a Friend
Oppenheimer analyst Francois Brisebois raised the price target on Avadel Pharmaceuticals (NASDAQ: AVDL) to $15.00 (from $13.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
